Metropolitan Life Insurance Company (MetLife)’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,004
| Closed | -$37.8K | – | 1078 |
|
|
2024
Q1 | $37.8K | Hold |
1,004
| – | – | ﹤0.01% | 1548 |
|
|
2023
Q4 | $10.8K | Hold |
1,004
| – | – | ﹤0.01% | 2156 |
|
|
2023
Q3 | $10.1K | Hold |
1,004
| – | – | ﹤0.01% | 2203 |
|
|
2023
Q2 | $11.9K | Hold |
1,004
| – | – | ﹤0.01% | 2208 |
|
|
2023
Q1 | $12.1K | Sell |
1,004
-378
| -27% | -$4.57K | ﹤0.01% | 2089 |
|
|
2022
Q4 | $18.2K | Hold |
1,382
| – | – | ﹤0.01% | 2066 |
|
|
2022
Q3 | $18.7K | Hold |
1,382
| – | – | ﹤0.01% | 2062 |
|
|
2022
Q2 | $16.9K | Hold |
1,382
| – | – | ﹤0.01% | 2123 |
|
|
2022
Q1 | $19.8K | Sell |
1,382
-2,629
| -66% | -$37.7K | ﹤0.01% | 2102 |
|
|
2021
Q4 | $79.1K | Hold |
4,011
| – | – | ﹤0.01% | 2598 |
|
|
2021
Q3 | $86.8K | Buy |
+4,011
| New | +$86.8K | ﹤0.01% | 2604 |
|